BWAYNasdaqSurgical & Medical Instruments & ApparatusAlso trades as BRSYF
Brainsway Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 20, 2026
$11.99+0.55 (+4.81%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 66.6
- Dividend yield
- –
Brainsway Ltd. revenue by segment
By business segment
By product or service
By region
| Revenue | TTM Q4 20 | TTM Q4 19 | % of revenue | YoY |
|---|---|---|---|---|
| Europes [Member] | $1.85M | $1.35M | 8.4% | +36.5% |
| Other [Member] | $730.00K | $845.00K | 3.3% | -13.6% |
From the segment and revenue-disaggregation notes of Brainsway's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.